TRINITY MEDICAL GROUP INC
SB-2, EX-10.6, 2000-10-20
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: TRINITY MEDICAL GROUP INC, SB-2, EX-10.5, 2000-10-20
Next: TRINITY MEDICAL GROUP INC, SB-2, EX-23.2, 2000-10-20




                              EMPLOYMENT AGREEMENT

After discussion,  the Board of Directors have determined an agreement to employ
Dr. James S. Namnath until December 31, 2000 as its Chief Executive Officer. His
employment will be conducted under contract  services with his present employer,
NotesETC,  Inc. until such time  ("Milestone") that TMGUSA either begins sale of
Remune  product or is approved  for public  trading of its common  shares in the
United States equity market as a reporting company;  after this time, he will be
directly employed by TMGUSA on a full time basis.

Until Milestone,  his compensation will be at a rate of $250 per hour but not to
exceed 60 hours per month ($15,000).

After Milestone his monthly salary will be $35,000 per month.

The employment is "At Will" and may be terminated at any time by the Company.

Dr.  Namnath is highly  compensated  due to his unique  record in  business  and
sciences. His hourly rate for services before Milestone is considered average to
below  average for a  professional  with a  doctorate  degree and over ten years
management  experiences.  His  post  Milestone  salary  is  competitive  in  the
bio-technology field and considered average.

Approved by the Board of Directors, TMGUSA, Inc.


/s/ Vina Churdboonchart
-----------------------------

/s/ Inthanom  Churdboonchart
-----------------------------

/s/ Orranart  Churdboonchart
-----------------------------

/s/ Elizabeth Namnath
-----------------------------
Secretary



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission